Tekla Capital Management LLC Bio Techne Corp Transaction History

Tekla Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $2.46 Million - $2.84 Million	-5,400 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $978,714 - $1.19 Million	-2,200 Reduced 28.95%	5,400 $2.62 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $13.9 Million - $18.1 Million	-44,110 Reduced 85.3%	7,600 $2.9 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $1.11 Million - $1.67 Million	-5,981 Reduced 10.37%	51,710 $13.7 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $1.22 Million - $1.68 Million	7,600 Added 15.17%	57,691 $10.9 Million
Q4 2019 Feb 13, 2020	BUY	$189.68 - $222.09 $3.71 Million - $4.34 Million	19,554 Added 64.03%	50,091 $11 Million
Q3 2019 Nov 13, 2019	BUY	$183.56 - $216.72 $1.62 Million - $1.91 Million	8,836 Added 40.72%	30,537 $5.98 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $2.95 Million - $4.35 Million	21,701 New	21,701 $4.31 Million

603

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.65B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.